GeneFriends: An online co-expression analysis tool to identify novel gene targets for aging and complex diseases

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  van Dam, Sipko ^a   Cordeiro, Rui ^a   Craig, Thomas ^a   van Dam, Jesse ^b   Wood, Shona H ^a   de Magalhães, João P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Aging; Cancer; Functional genomics; Mitochondrial disease; Network biology

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

AGING; ARTICLE; C EBP GENE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ASSOCIATION; HELA CELL; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONLINE SYSTEM; VALIDATION PROCESS;

AGING; ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; ELECTRON TRANSPORT COMPLEX I; HUMANS; INTERNET; MICE; MITOCHONDRIAL DISEASES; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84867016547     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-535     Document Type: Article

References (86)

1. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002, 287:1662-1670. 10.1001/jama.287.13.1662, 11926890.
2. Tanwar MK, Gilbert MR, Holland EC. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 2002, 62:4364-4368.
3. Mok SC, Chao J, Skates S, Wong K, Yiu GK, et al. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst 2001, 93:1458-1464. 10.1093/jnci/93.19.1458, 11584061.
4. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002, 161:1991-1996. 10.1016/S0002-9440(10)64476-8, 1850928, 12466114.
5. Ye QH, Qin LX, Forgues M, He P, Kim JW, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003, 9:416-423. 10.1038/nm843, 12640447.
6. Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 2003, 3:173-183. 10.1016/S1535-6108(03)00003-5, 12620411.
7. Stuart JM, Segal E, Koller D, Kim SK. A gene-coexpression network for global discovery of conserved genetic modules. Science 2003, 302:249-255. 10.1126/science.1087447, 12934013.
8. Aid-Pavlidis T, Pavlidis P, Timmusk T. Meta-coexpression conservation analysis of microarray data: a "subset" approach provides insight into brain-derived neurotrophic factor regulation. BMC Genomics 2009, 10:420. 10.1186/1471-2164-10-420, 2748098, 19737418.
9. Obayashi T, Hayashi S, Shibaoka M, Saeki M, Ohta H, et al. COXPRESdb: a database of coexpressed gene networks in mammals. Nucleic Acids Res 2008, 36:D77-82. 10.1093/nar/gkn358, 2238883, 17932064.
10. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868. 10.1073/pnas.95.25.14863, 24541, 9843981.
11. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, et al. Functional discovery via a compendium of expression profiles. Cell 2000, 102:109-126. 10.1016/S0092-8674(00)00015-5, 10929718.
12. Kim SK, Lund J, Kiraly M, Duke K, Jiang M, et al. A gene expression map for Caenorhabditis elegans. Science 2001, 293:2087-2092. 10.1126/science.1061603, 11557892.
13. Walker MG, Volkmuth W, Sprinzak E, Hodgson D, Klingler T. Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes. Genome Res 1999, 9:1198-1203. 10.1101/gr.9.12.1198, 310991, 10613842.
14. Walker MG, Volkmuth W, Klingler TM. Pharmaceutical target discovery using Guilt-by-Association: schizophrenia and Parkinson's disease genes. Proc Int Conf Intell Syst Mol Biol 1999, 282-286.
15. Wu X, Walker MG, Luo J, Wei L. GBA server: EST-based digital gene expression profiling. Nucleic Acids Res 2005, 33:W673-676. 10.1093/nar/gki480, 1160240, 15980560.
16. de Magalhaes JP, Budovsky A, Lehmann G, Costa J, Li Y, et al. The Human Ageing Genomic Resources: online databases and tools for biogerontologists. Aging Cell 2009, 8:65-72. 10.1111/j.1474-9726.2008.00442.x, 2635494, 18986374.
17. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 2009, 4:44-57.
18. de Magalhaes JP, Curado J, Church GM. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 2009, 25:875-881. 10.1093/bioinformatics/btp073, 2732303, 19189975.
19. Saftig P, Eskelinen EL. Live longer with LAMP-2. Nat Med 2008, 14:909-910. 10.1038/nm0908-909, 18776878.
20. Yajima N, Sakamaki K, Yonehara S. Age-related thymic involution is mediated by Fas on thymic epithelial cells. Int Immunol 2004, 16:1027-1035. 10.1093/intimm/dxh104, 15192051.
21. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003, 144:3799-3810. 10.1210/en.2003-0374, 12933651.
22. Miwa N, Uebi T, Kawamura S. S100-annexin complexes-biology of conditional association. FEBS J 2008, 275:4945-4955. 10.1111/j.1742-4658.2008.06653.x, 18795952.
23. Guruceaga E, Segura V, Corrales FJ, Rubio A. FactorY, a bioinformatic resource for genome-wide promoter analysis. Comput Biol Med 2009, 39:385-387. 10.1016/j.compbiomed.2009.01.008, 19272592.
24. Nasmyth K. Segregating sister genomes: the molecular biology of chromosome separation. Science 2002, 297:559-565. 10.1126/science.1074757, 12142526.
25. Blachon S, Gopalakrishnan J, Omori Y, Polyanovsky A, Church A, et al. Drosophila asterless and vertebrate Cep152 Are orthologs essential for centriole duplication. Genetics 2008, 180:2081-2094. 10.1534/genetics.108.095141, 2600943, 18854586.
26. Foltz DR, Jansen LE, Black BE, Bailey AO, Yates JR, et al. The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol 2006, 8:458-469. 10.1038/ncb1397, 16622419.
27. Jallepalli PV, Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat Rev Cancer 2001, 1:109-117. 10.1038/35101065, 11905802.
28. Hayama S, Daigo Y, Yamabuki T, Hirata D, Kato T, et al. Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis. Cancer Res 2007, 67:4113-4122. 10.1158/0008-5472.CAN-06-4705, 17483322.
29. Macurek L, Lindqvist A, Medema RH. Aurora-A and hBora join the game of Polo. Cancer Res 2009, 69:4555-4558. 10.1158/0008-5472.CAN-09-0142, 19487276.
30. Gonzalez S, Klatt P, Delgado S, Conde E, Lopez-Rios F, et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006, 440:702-706. 10.1038/nature04585, 16572177.
31. Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med 2008, 5:e184. 10.1371/journal.pmed.0050184, 2528050, 18767902.
32. Berrier A, Siu G, Calame K. Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J Immunol 1998, 161:2267-2275.
33. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991, 67:569-579. 10.1016/0092-8674(91)90531-3, 1934061.
34. Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, et al. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 2004, 40:356-365.
35. Chiu CH, Lin WD, Huang SY, Lee YH. Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev 2004, 18:1970-1975. 10.1101/gad.1213104, 514177, 15289464.
36. Karagiannides I, Tchkonia T, Dobson DE, Steppan CM, Cummins P, et al. Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1772-1780.
37. de Magalhaes JP, Cabral JA, Magalhaes D. The influence of genes on the aging process of mice: a statistical assessment of the genetics of aging. Genetics 2005, 169:265-274. 1448866, 15466429.
38. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395. 2786175, 19587680.
39. Calkhoven CF, Muller C, Leutz A. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev 2000, 14:1920-1932. 316813, 10921906.
40. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets?. Nat Rev Cancer 2007, 7:495-507. 10.1038/nrc2169, 17568790.
41. Lazo JS, Wipf P. Is Cdc25 a druggable target?. Anticancer Agents Med Chem 2008, 8:837-842. 2752834, 19075566.
42. Brezak MC, Kasprzyk PG, Galcera MO, Lavergne O, Prevost GP. CDC25 inhibitors as anticancer agents are moving forward. Anticancer Agents Med Chem 2008, 8:857-862.
43. Lavecchia A, Di Giovanni C, Novellino E. Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review. Expert Opin Ther Pat 2010, 20:405-425. 10.1517/13543771003623232, 20166845.
44. Montagnoli A, Moll J, Colotta F. Targeting cell division cycle 7 kinase: a new approach for cancer therapy. Clin Cancer Res 2010, 16:4503-4508. 10.1158/1078-0432.CCR-10-0185, 20647475.
45. Morgan H, Beck T, Blake A, Gates H, Adams N, et al. EuroPhenome: a repository for high-throughput mouse phenotyping data. Nucleic Acids Res 2010, 38:D577-585. 10.1093/nar/gkp1007, 2808931, 19933761.
46. Piao L, Nakagawa H, Ueda K, Chung S, Kashiwaya K, et al. C12ORF48, termed PARP-1 binding protein, enhances poly(ADP-ribose) polymerase-1 (PARP-1) activity and protects pancreatic cancer cells from DNA damage. Genes Chromosomes Cancer 2011, 50:13-24. 10.1002/gcc.20828, 20931645.
47. Lebon S, Chol M, Benit P, Mugnier C, Chretien D, et al. Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. J Med Genet 2003, 40:896-899. 10.1136/jmg.40.12.896, 1735336, 14684687.
48. Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, et al. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J Clin Invest 2004, 114:837-845. 516258, 15372108.
49. Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000, 15:123-134. 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P, 10649489.
50. Pitkanen S, Feigenbaum A, Laframboise R, Robinson BH. NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis 1996, 19:675-686. 10.1007/BF01799845, 8892026.
51. Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta 1998, 1364:271-286. 10.1016/S0005-2728(98)00033-4, 9593934.
52. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999, 283:1482-1488. 10.1126/science.283.5407.1482, 10066162.
53. Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JA. Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis 2006, 29:499-515. 10.1007/s10545-006-0362-4, 16838076.
54. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123. 10.1016/j.cell.2008.06.016, 2778844, 18614015.
55. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, et al. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res 2007, 35:D760-765. 10.1093/nar/gkl887, 1669752, 17099226.
56. Lage K, Hansen NT, Karlberg EO, Eklund AC, Roque FS, et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A 2008, 105:20870-20875. 10.1073/pnas.0810772105, 2606902, 19104045.
57. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999, 96:8681-8686. 10.1073/pnas.96.15.8681, 17576, 10411935.
58. Li Q, Ahuja N, Burger PC, Issa JP. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 1999, 18:3284-3289. 10.1038/sj.onc.1202663, 10359534.
59. Phillips DR, Jennings LK, Prasanna HR. Ca2 + -mediated association of glycoprotein G (thrombinsensitive protein, thrombospondin) with human platelets. J Biol Chem 1980, 255:11629-11632.
60. Linsalata M, Giannini R, Notarnicola M, Cavallini A. Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 2006, 6:191. 10.1186/1471-2407-6-191, 1543652, 16854216.
61. Starlets D, Gore Y, Binsky I, Haran M, Harpaz N, et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 2006, 107:4807-4816. 10.1182/blood-2005-11-4334, 16484589.
62. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002, 196:1507-1513. 10.1084/jem.20020897, 2194267, 12461085.
63. Piredda L, Farrace MG, Lo Bello M, Malorni W, Melino G, et al. Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J 1999, 13:355-364.
64. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002, 27:534-539. 10.1016/S0968-0004(02)02182-5, 12368090.
65. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res 2004, 53:125-132. 10.1007/s00011-003-1235-z, 15060718.
66. Grewal T, Enrich C. Annexins-modulators of EGF receptor signalling and trafficking. Cell Signal 2009, 21:847-858. 10.1016/j.cellsig.2009.01.031, 19385045.
67. Hart PS, Pallos D, Zhang Y, Sanchez J, Kavamura I, et al. Identification of a novel cathepsin C mutation (p.W185X) in a Brazilian kindred with Papillon-Lefevre syndrome. Mol Genet Metab 2002, 76:145-147. 10.1016/S1096-7192(02)00031-8, 12083812.
68. Hewitt C, McCormick D, Linden G, Turk D, Stern I, et al. The role of cathepsin C in Papillon-Lefevre syndrome, prepubertal periodontitis, and aggressive periodontitis. Hum Mutat 2004, 23:222-228. 10.1002/humu.10314, 14974080.
69. Anderson RA, Byrum RS, Coates PM, Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A 1994, 91:2718-2722. 10.1073/pnas.91.7.2718, 43441, 8146180.
70. Tinari N, Kuwabara I, Huflejt ME, Shen PF, Iacobelli S, et al. Glycoprotein 90 K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation. Int J Cancer 2001, 91:167-172. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q, 11146440.
71. Beauchamp NJ, Daly ME, Makris M, Preston FE, Peake IR. A novel mutation in intron K of the PROS1 gene causes aberrant RNA splicing and is a common cause of protein S deficiency in a UK thrombophilia cohort. Thromb Haemost 1998, 79:1086-1091.
72. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984, 311:1525-1528. 10.1056/NEJM198412133112401, 6239102.
73. Biddinger SB, Miyazaki M, Boucher J, Ntambi JM, Kahn CR. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes 2006, 55:2032-2041. 10.2337/db05-0742, 16804073.
74. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575. 1222736, 12006103.
75. Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, et al. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A 1998, 95:10908-10913. 10.1073/pnas.95.18.10908, 27994, 9724803.
76. Gigliotti AP, Johnson PF, Sterneck E, DeWille JW. Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia. Exp Biol Med (Maywood) 2003, 228:278-285.
77. Huang AM, Montagna C, Sharan S, Ni Y, Ried T, et al. Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene 2004, 23:1549-1557. 10.1038/sj.onc.1207285, 14716301.
78. O'Connell BC, Adamson B, Lydeard JR, Sowa ME, Ciccia A, et al. A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic Stability. Mol Cell 2010, 40:645-657. 10.1016/j.molcel.2010.10.022, 3006237, 21055985.
79. Ohta S, Shiomi Y, Sugimoto K, Obuse C, Tsurimoto T. A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein. J Biol Chem 2002, 277:40362-40367. 10.1074/jbc.M206194200, 12171929.
80. Sawa M, Masai H. Drug design with Cdc7 kinase: a potential novel cancer therapy target. Drug Des Devel Ther 2009, 2:255-264. 2761190, 19920912.
81. Okada M, Cheeseman IM, Hori T, Okawa K, McLeod IX, et al. The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol 2006, 8:446-457. 10.1038/ncb1396, 16622420.
82. Suzuki C, Daigo Y, Ishikawa N, Kato T, Hayama S, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res 2005, 65:11314-11325. 10.1158/0008-5472.CAN-05-1507, 16357138.
83. Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 2003, 64:2291-2297. 10.1046/j.1523-1755.2003.00334.x, 14633154.
84. Beauchemin AM, Gottlieb B, Beitel LK, Elhaji YA, Pinsky L, et al. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res Bull 2001, 56:285-297. 10.1016/S0361-9230(01)00583-4, 11719263.
85. Kaput J, Swartz D, Paisley E, Mangian H, Daniel WL, et al. Diet-disease interactions at the molecular level: an experimental paradigm. J Nutr 1994, 124:1296S-1305S.
86. Barstead RJ, Waterston RH. Vinculin is essential for muscle function in the nematode. J Cell Biol 1991, 114:715-724. 10.1083/jcb.114.4.715, 2289884, 1907975.